• Ghulam Farooq Hayatabad Medical Complex, Peshawar, Pakistan
  • Khalid Shahab Medical B Unit, Hayatabad Medical Complex, Peshawar
  • Muhammad Ishfaq Medical B Unit, Hayatabad Medical Complex, Peshawar.
  • Mumtaz Ali Marwat Medical B Unit, Hayatabad Medical Complex, Peshawar.
  • Ghulam Rabbani Anwar PGR, Medical B Unit, Hayatabad Medical Complex, Peshawar.
  • Muhammad Shahid Iqbal Neurology ward, Rehman Medical Institute, Peshawar.
Keywords: Albuminuria, hypertension, diabetes mellitus, ischemic stroke, peshawar


Background: Stroke, and its most common variant ischemic stroke, is one of the major causes of morbidity and mortality worldwide. Besides conventional risk factors, microalbuminuria (MA) is considered to be associated with atherosclerosis, hence ischemic stroke. Early detection of microalbuminuria may help in identifying hypertensive patients at high risk of ischemic stroke. The aim of current study was to determine the frequency of microalbuminuria in hypertensive patients with ischemic stroke. Methodology: This cross-sectional study was conducted at the Department of Medicine, Hayatabad Medical Complex Peshawar, Pakistan from July 2020 to June 2021. A total of 196 hypertensive patients of either sex with ischemic stroke were included in this study. They were tested for microalbuminuria in a 24-hours urine sample using Pyrogallol Red method. Urine albumin concentration of 30–300 mg/day was considered as microalbuminuria. The frequency of microalbuminuria was stratified according to age and gender using Microsoft Excel sheet. Results: The participants were aged 30–70 years and most of them (88, 45%) were in the age group 61–70 years. Majority (122, 62%) of the patients were male. Microalbuminuria was identified in 92 (47%) patients with slight male predominance (57, 62%). Conclusion: Given the high frequency of Microalbuminuria in hypertensive patients with acute ischemic stroke, microalbuminuria is a useful and inexpensive parameter in identifying hypertensive patients at increased risk of ischemic stroke.

Pak J Physiol 2022;18(2):35‒7


Lakomkin N, Dhamoon M, Carroll K, Singh IP, Tuhrim S, Lee J, et al. Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke: a 10-year systematic review of the literature. J Neurointerv Surg 2019;11(3):241–5.

Li T, Horton RM, Bader DA, Liu F, Sun Q, Kinney PL. Long-term projections of temperature-related mortality risks for ischemic stroke, hemorrhagic stroke, and acute ischemic heart disease under changing climate in Beijing, China. Environ Int 2018;112:1–9.

Johnson W, Onuma O, Owolabi M, Sachdev S. Stroke: a global response is needed. Bull World Health Organ 2016;94(9):634.

Venketasubramanian N, Yoon BW, Pandian J, Navarro JC. Stroke epidemiology in south, east, and south-east Asia: a review. J Stroke. 2017;19(3):286–294.

Sharif F, Ghulam S, Sharif A. Prevalence of risk factors associated with stroke. Pak Heart J 2019;52(1):91–5.

Arboix A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases 2015;3(5):418–29.

Vangen-Lønne AM, Wilsgaard T, Johnsen SH, Løchen M-L, Njølstad I, Mathiesen EB. Declining incidence of ischemic stroke: what is the impact of changing risk factors? The Tromsø Study 1995 to 2012. Stroke 2017;48(3):544–50.

Parving H-H, Persson F, Rossing P. Microalbuminuria: a parameter that has changed diabetes care. Diabetes Res Clin Pract 2015;107(1):1–8.

Viazzi F, Cappadona F, Pontremoli R. Microalbuminuria in primary hypertension: a guide to optimal patient management? J Nephrol 2016;29(6):747–53.

Singh K, Kumar P, Joshi A, Shivhare DK, Mahto SK, Singh A, et al. Study of association of serum uric acid with albuminuria and carotid atherosclerosis in type 2 diabetes mellitus patients. J Family Med Prim Care 2019;8(12):4027–31.

Li F, Chen Q-X, Peng B, Chen Y, Yao T, Wang G. Microalbuminuria in patients with acute ischemic stroke. Neurol Res 2019;41(6):498–503.

Gaurav DK, Malik R, Rani A, Dua A. Study of microalbuminuria in acute ischemic stroke and its correlation with severity. Indian J Med Spec 2020;11(4):212–6.

Zakria M, Sarfraz M, Ahmad T. Microalbuminuria. The Professional Med J 2017;24(1):126–31.

Thampy A, Pais CC. Early clinical implications of microalbuminuria in patients with acute ischaemic stroke. J Clin Diagn Res 2016;10(9):OC29–OC31.

Farooq MA, Anjum MS, Malik FA, Kalsoom N. Frequency of microalbuminuria in patients with ischemic stroke. Rawal Med J 2013;38(2):97–9.

Liao P, Klasnja P, Tewari A, Murphy SA. Sample size calculations for micro‐randomized trials in mHealth. Stat Med 2016;35(12):1944–71.

Chowdhury J, Sultana N, Ahmed S, Rahman M, Akter M, Rafique T. Microalbuminuria as a predictor of short-term mortality in acute ischemic stroke. Bangladesh J Med Biochem 2012;5(1):16–9.

Turaj W, Slowik A, Wyrwicz-Petkow U, Pankiewicz J, Iskra T, Rudzinska M, et al. The prognostic significance of microalbuminuria in non-diabetic acute stroke patients. Med Sci Monit 2001;7(5):989–94.

Yuyun M, Khaw KT, Luben R, Welch A, Bingham S, Day N, et al. Microalbuminuria and stroke in a British population: the European prospective investigation into cancer in Norfolk (EPIC‐Norfolk) population study. J Int Med 2004;255(2):247–56.

Ovbiagele B. Microalbuminuria: risk factor and potential therapeutic target for stroke? J Neurol Sci 2008;271(1-2):21–8.


Download data is not yet available.
How to Cite
Farooq G, Shahab K, Ishfaq M, Marwat M, Anwar G, Iqbal M. FREQUENCY OF MICROALBUMINURIA IN HYPERTENSIVE PATIENTS WITH ACUTE ISCHEMIC STROKE. PJP [Internet]. 30Jun.2022 [cited 26Nov.2022];18(2):35-7. Available from:

Most read articles by the same author(s)